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Abstract: Hypoxia is one of the most frequently encountered stress factors in both health and disease. Intermittent 
hypoxia (IH) is the most common pattern of hypoxic exposure. Osteoprotegerin (OPG) is produced by various cell 
types, including hepatocytes. Alterations in serum and tissue levels of OPG have been linked to many types of dis-
eases, and clinical significance of OPG expression status has recently been clarified. However, the effect of IH on the 
expression of OPG in the liver remains unknown. The aim of this study was to investigate the effect of IH on hepatic 
OPG expression. Male Sprague-Dawley rats were placed in a hypobaric chamber (282 mm Hg, 30 min/d, 14 d). He-
patic OPG mRNA and protein levels were determined using quantitative real-time RT-PCR and immunohistochemical 
staining, respectively. A significant decline in hepatic OPG expression at both mRNA and protein levels was reported 
in the IH model. In hypoxic rats, IH significantly decreased the OPG mRNA expression, when compared with the nor-
moxic control (P=0.001). Immunohistochemistry revealed that the normoxic livers exhibited a moderate to strong, 
homogeneous cytoplasmic staining of hepatocytes. In contrast, all the hypoxic livers showed a significantly reduced 
OPG staining intensity, when compared with the normoxic livers. In 9 of the 12 (75.0%) hypoxic rats, hepatic OPG 
immunoreactivity was undetectable. Our preliminary data suggest that IH exposure downregulates hepatic OPG at 
both the transcriptional and translational levels. Further investigations are necessary to clarify the mechanism by 
which hypoxia would induce OPG downregulation.
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Introduction
The aerospace environment has negative 
effects on bodily function, resulting in malfunc-
tion of vital organs. Flight surgeons continually 
seek to determine and understand pilots’ phys-
iological responses to hypoxia and the patho-
physiological mechanisms involved. Advanced 
aircraft design has made it increasingly possi-
ble to fly at higher altitudes. However, the pos-
sibility of experiencing hypoxia still exists, not 
only in pilots and cabin crews but also in 
patients who are being transported by military 
or civilian airlines [1]. Because symptoms of 
hypoxia can vary with each individual, the abili-
ty to recognize and address hypoxia can be 
greatly improved by experiencing and observ-
ing its effects. It is critically important that 
pilots, cabin crews, and medical professionals 
should be very familiar with hypoxia and the fac-
tors that affect its presentation. 
Hypoxia is one of the most frequently encoun-
tered stress factors in both health and disease, 
and it is often implied as the common cause of 
tissue and cell injury. However, recent studies 
have indicated that the effects of hypoxia on 
the body can vary depending on the duration, 
severity, and frequency of hypoxic exposure [2]. 
Individuals may be exposed to acute, chronic, 
or intermittent hypoxia (IH) during their life. The 
effects of acute and chronic hypoxia have been 
assessed over many decades. However, stud-
ies on IH, the most common pattern of hypoxic 
exposure, have just begun in recent years. IH is 
defined as repeated episodes of hypoxia inter-
spersed with normoxic breathing [2]. IH may be 
observed in both physiological and pathophysi-
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ological conditions such as during severe ex- 
ercise, air travel, obstructive sleep apnea, 
exposure to altitude, and various respiratory 
diseases.
Osteoprotegerin (OPG) has been recently iden-
tified as a member of the tumor necrosis factor 
(TNF) receptor family, whose best character-
ized activity is the inhibition of receptor activa-
tor of nuclear factor-κB ligand-stimulated for-
mation of osteoclasts [3-5]. OPG can also sti- 
mulate cell survival by acting as a receptor for 
TNF-related apoptosis-inducing ligand (TRAIL) 
[6]. There is growing evidence that OPG plays 
key roles in regulating numerous physiologic- 
al and pathophysiological processes. It is wi- 
dely accepted that OPG plays a central role in 
the regulation of bone turnover and a number 
of studies have assessed the role of OPG in 
bone-related diseases including osteoporosis, 
Paget’s disease, and arthritis [7-10]. Moreover, 
OPG appears to have a vascular role, and in par- 
ticular, it appears to prevent processes involved 
in atherosclerosis [11, 12]. With respect to 
tumorigenesis, the role of OPG appears to be 
more complex. The ability of OPG to inhibit the 
development of cancer-induced bone diseases 
suggests that OPG is effective at inhibiting this 
process [13]; however, paradoxically, evidence 
that OPG can inhibit TRAIL-induced apoptosis 
of cancer cells suggests that OPG is pro-tumor-
igenic [14]. Although the role of OPG in a num-
ber of diseases is beginning to emerge, there is 
a need to further elucidate whether OPG is pro-
tective or detrimental, and potential mecha-
nisms by which OPG may act.
It has been shown that exposure to hypoxia 
affects the production and release of OPG, but 
the effect of IH on OPG expression remains 
unknown. Furthermore, alteration in the hepat-
ic expression of OPG following exposure to IH 
has not yet been investigated. The aim of this 
study was to examine the expression of OPG 
mRNA and protein in the livers of rats exposed 
to 14 d of IH and to investigate whether expo-
sure to IH can lead to significant changes in the 




Sixteen male Sprague-Dawley rats weighing 
between 200 and 230 g were used. The ani-
mals were randomly divided into IH and nor-
moxic control groups. To obtain IH, 12 rats were 
placed in an altitude chamber at a barometric 
pressure of 282 mm Hg, corresponding to an 
altitude of 7,620 m (approximately 25,000 ft; 
equal to 7% oxygen at sea level). The tempera-
ture and moisture of the chamber were main-
tained at 20-24°C and 45%, respectively, with 
12-h light and dark cycles. The rats of the IH 
group (n=12) were kept at this barometric pres-
sure for 30 min/d for 14 d. The rats of the con-
trol group (n=4) stayed in the same environ-
ment as those of the IH group with access to 
food and water ad libitum, with the exception of 
breathing normal room air. The chamber was 
opened daily to clean the cages and replenish 
food and water. At the end of exposure to IH, 
both groups of animals were anesthetized by 
carbon dioxide. For tissue collection, the rats 
were laparotomized via a midline incision. A 
portion of each liver was fixed in 10% neutral 
buffered formalin for immunohistochemical 
staining. The remaining tissue was partitioned 
and immediately stored under frozen liquid 
nitrogen at -80°C until reverse-transcriptase 
polymerase chain reaction (RT-PCR) analysis 
was performed. The care of animals and eutha-
nasia procedures were performed in accor-
dance with the guidelines established by the 
National Institute of Health. This study was 
approved by the Institutional Animal Care and 
Use Committee (IACUC) of the Republic of 
Korea Air Force Aerospace Medical Center 
(Protocol No.: ASMC-14-IACUC-003).
Quantitative real-time reverse transcriptase-
polymerase chain reaction analysis
Quantitative real-time RT-PCR was performed 
on the Bio-Rad CFX96 Real-Time PCR Detection 
System (Bio-Rad Laboratories, Hercules, CA, 
USA) with the C1000 Thermal Cycler (Bio-Rad 
Laboratories). Total serum RNA was isolated 
using the NucleoSpin RNA II extraction kit 
(Macherey-Nagel, Dueren, Germany), according 
to the manufacturer’s instructions. cDNA syn-
thesis was performed with the ReverTra Ace-α- 
reverse transcriptase kit (Toyobo, Osaka, 
Japan), according to the manufacturer’s instruc-
tions. The amount of standard cDNA was deter-
mined photometrically. The reverse-transcribed 
cDNA was used for the real-time RT-PCR reac-
tion using SsoAdvanced SYBR Green Supermix 
(Bio-Rad Laboratories). The following primer 
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sequence of OPG used: forward 5’-GGCAAGT- 
TGACCGTTAGC-3’; reverse 5’-GGAACAAGAAA- 
CACTGGACTC-3’. The following primer sequence 
of GAPDH was used: forward 5’-CATAGACAAG- 
ATGGTGAAGGT-3’; reverse 5’-AGTTGAGGTCAA- 
TGAAGGG-3’. The PCR reactions for OPG and 
GAPDH were initiated with a denaturing step at 
95°C for 3 min, followed by 40 cycles at 95°C 
for 10 sec, 58°C for 10 sec and 72°C for 20 
sec. A melting curve, ramping from 65°C to 
95°C, was performed following each RT-PCR to 
test for the presence of primer dimers. When 
primer dimer formation was detected, the PCR 
was ran again using a separate aliquot of cDNA. 
Each measurement was repeated three times, 
and the values were used to calculate the ratio 
of OPG/GAPDH, with a value of 1.0 used as the 
control (calibrator).
Immunohistochemistry
Formalin-fixed liver tissue was dehydrated in a 
graded series of ethanol and embedded in par-
affin. Paraffin blocks were sectioned at 4 μm on 
a standard rotary microtome, and the slices 
were transferred from a water bath onto clean- 
ed slides. OPG protein expression was asse- 
ssed by immunohistochemical staining using 
the Bond Polymer Intense Detection System 
(Vision Bio-Systems, Mount Waverley, Victoria, 
Australia), following the manufacturer’s instruc-
tions. To summarize, 4-μm sections of formalin-
fixed, paraffin-embedded tissue were deparaf-
finized with Bond Dewax Solution (Vision Bio- 
Systems), and an antigen retrieval procedure 
was performed using Bond ER Solution (Vision 
BioSystems) for 30 min at 100°C. Endogenous 
peroxidases were quenched by incubation with 
hydrogen peroxide for 5 min. The sections were 
incubated for 15 min at ambient temperature 
with a rabbit polyclonal anti-OPG antibody 
(1:100, Abcam, Cambridge, MA, USA). The bio-
tin-free polymeric horseradish peroxidase-link-
er antibody conjugate system was used in the 
Bond-maX automatic slide stainer (Vision Bio- 
Systems), and visualization was performed by 
using a 3.3-diaminobenzidine (DAB) solution (1 
mM DAB, 50 mM Tris-HCl buffer [pH 7.6] and 
0.006% H2O2). The sections were then counter-
stained with hematoxylin. Slides were subse-
quently dehydrated following a standard proce-
dure and sealed with coverslips. In order to 
minimize interassay variation, positive and ne- 
gative control samples were included in each 
run. The positive control sample was normal 
liver tissue. The negative control was prepared 
by substituting non-immune serum for the pri-
mary antibody; no detectable staining was 
evident.
The immunohistochemical staining was ana-
lyzed by an experienced pathologist. The OPG 
Figure 1. A. OPG mRNA expression in control (open bars) and IH (solid bars) groups. Effect of exposure to IH on OPG 
mRNA expression in the liver of Sprague-Dawley rats was examined using quantitative real-time RT-PCR analysis. 
Results are mean values of three independent experiments with each animal. Eleven of the 12 rats exposed to IH 
showed lower levels of OPG mRNA expression than the normoxic rats. Exposure to IH resulted in a significant de-
crease in the mean OPG mRNA level by 0.15-fold, when compared to that in the control group (P<0.001). B. Hepatic 
OPG immunoreactivity in control and IH groups. The normoxic livers (n=4) exhibited a moderate (2/4; 50.0%) to 
strong (2/4; 50.0%), homogeneous cytoplasmic staining of hepatocytes. In contrast, all the hypoxic livers showed a 
significant reduction in staining intensity of OPG-positive hepatocytes [negative, 9/12 (75.0%); weak, 2/12 (16.7%); 
moderate, 1/12 (8.3%)], when compared with that the normoxic livers.
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staining intensity of the hepatocytes in each 
sample was graded as negative, weak, moder-
ate or strong, as described previously [15]. 
There was no heterogeneity of staining within 
individual slides; estimation of the proportion 
of staining was not required. Disagreements 
between the two pathologists were resolved by 
consensus.
Statistical analysis
Measurements are presented as mean ± stan-
dard error. Statistical significance of the differ-
ence in OPG mRNA levels between control and 
IH groups was determined by the Mann-Whitney 
U-test. The Fisher’s exact test was performed 
to compare OPG protein expression between 
control and IH groups. The relationship between 
the levels of OPG protein and mRNA expression 
was examined using the Spearman’s rank cor-
relation coefficient. Statistical analyses were 
performed using the PASW Statistics for 
Windows (version 18.0; IBM SPSS Inc., Chicago, 
IL, USA). Statistical significance was defined as 
a P value of less than 0.05.
Results
OPG mRNA expression in the livers of rats 
exposed to IH
We performed real-time RT-PCR to measure the 
expression of OPG mRNA transcripts in 4 fresh 
normoxic livers and 12 fresh hypoxic livers. 
Compared with the normoxic livers, the hypoxic 
livers showed reduced expression levels of 
OPG mRNA. Eleven (91.6%) of the 12 rats 
exposed to IH showed lower levels of OPG 
mRNA expression than the normoxic rats 
(Figure 1A). The mean value of normalized 
OPG/GAPDH mRNA expression ratio in the IH 
group (0.411 ± 0.088; range, 0.128-1.034) 
was significantly lower than that in the control 
group (2.868 ± 0.808; range, 1.000-4.576) by 
0.15-fold (P=0.001).
OPG immunoreactivity in the livers of rats 
exposed to IH
Representative photomicrographs of OPG sta- 
ining intensity are shown in Figure 1B. Imm- 
unohistochemical staining revealed that the 
normoxic livers exhibited a moderate to strong, 
homogeneous cytoplasmic staining of hepato-
cytes. OPG was expressed in the cytoplasm of 
hepatocytes, as well as in other cell types, 
including bile duct epithelial cells and activated 
Kupffer cells, and in inflammatory cells includ-
ing plasma cells and lymphocytes. In contrast, 
all the hypoxic livers showed a significant reduc-
tion in staining intensity of OPG-positive hepa-
tocytes, when compared with the normoxic liv-
ers. In 9 of the 12 (75.0%) hypoxic rats, hepatic 
OPG immunoreactivity was undetectable (nega-
tive; Table 1). Of the remaining 3 hypoxic rats, 2 
(16.7%) rats displayed weak staining intensity, 
and 1 (8.3%) rat exhibited moderate staining 
intensity. Two (50.0%) of the 4 control rats had 
strong OPG immunoreactivity, and the remain-
ing 2 (50.0%) had moderate reactivity. Corre- 
lation between mRNA expression and immuno-
histochemical staining intensity was statisti-
cally significant (P<0.001; rank correlation 
coefficient, 0.860).
Discussion
Simonet and colleagues [4] observed OPG 
mRNA expression in a number of murine tis-
sues, including liver, lung, heart, and kidneys. 
Yasuda and colleagues [5] also showed that 
OPG is highly expressed in human liver, thyroid, 
kidney, colon, and spinal cord. Even though 
OPG is known to have an important role in 
osteoclastogenesis, a variety of cellular func-
tions of OPG have been noted in different types 
of human tissues and cells. Vidal and col-
leagues [16] reported that OPG is constitutively 
produced by human colonic epithelium, and 
OPG may represent an important mucosal 
immunoregulatory factor.
Some previous studies have documented OPG 
expression in normal and diseased livers. 
Moschen and colleagues [17] demonstrated a 
moderate, uniform cytoplasmic OPG immuno-
reactivity in the hepatocytes of normal human 
liver. Guanabens and colleagues [18] showed 




Number of samples (%)
P value
Control group IH group
Strong 2 (50.0) 0 0.001*
Moderate 2 (50.0) 1 (8.3)
Weak 0 2 (16.7)
Negative 0 9 (75.0)
*Statistically significant.
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that the serum OPG level is significantly altered 
in patients with chronic liver disease. The role 
of OPG has been studied in several types of 
liver disease, but the association between 
exposure to hypoxia and hepatic OPG expres-
sion has not yet been investigated.
We observed that exposure to IH resulted in a 
significant decrease in OPG mRNA and protein 
expression. Our results are in accordance with 
previous data reported by Shirakura and col-
leagues [19] who demonstrated that hypoxia 
significantly downregulated the expression of 
OPG mRNA and protein in mouse chondrocytes 
and human oral squamous cell carcinoma cells. 
There is no available data on the mechanism by 
which hypoxia would induce OPG downregula-
tion. Based on the finding that activated p53 
pathway downregulates OPG mRNA and protein 
expression in vascular endothelial cells [20], 
we speculated that hypoxia might be involved 
in the downregulation of OPG expression in the 
liver of rats by activating p53. The p53 protein 
has been reported to be stimulated and to 
accumulate in different cell lines under hypoxia 
[21]. This accumulation may increase with the 
duration of hypoxia incubation as well as the 
decrease in the oxygen level. Zhao and col-
leagues [22] observed that hypoxic exposure 
mimicking an altitude of 5,000 m for 8 h signifi-
cantly increased TP53 mRNA and p53 protein 
expression levels in the liver of rats, and at an 
altitude of 7,000 m p53 expression was further 
increased. Moreover, when the 7,000 m chal-
lenge was extended to 24 h, the p53 mRNA 
level was maintained at a significantly high 
level. Further investigations are warranted to 
clarify the relationship between p53 and OPG 
expression in hypoxic conditions.
In contrast, contradictory data have been re- 
ported. Gao and colleagues [23] demonstrated 
that OPG expression was increased under 
hypoxic conditions in metastatic hepatocellular 
carcinoma cells. Meanwhile, Mandelin and col-
leagues [24] found that the pro-inflammatory 
cytokine TNF-α caused a marked increase in 
OPG mRNA levels in human endothelial cells, 
whereas hypoxia did not stimulate the endothe-
lial cells to produce OPG mRNA. These findings 
raise the possibility that hypoxia was less likely 
to modulate the TNF-α-induced OPG production 
and that OPG expression in human endothelial 
cells was not dependent on the oxygen level.
In conclusion, our preliminary data demonstrat-
ed that IH exposure downregulates hepatic 
OPG at both the transcriptional and translation-
al levels. Further investigations are necessary 
to clarify the mechanism by which hypoxia 
would induce downregulation of hepatic OPG 
expression.
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